In other cancers, the anticancer mechanism of parthenolide is believed to be mainly related to the inhibition of NF-κB, and other mechanisms include the inhibition of mouse double minute 2 homolog (MDM2), HDAC1, transcription protein 3 (STAT3), and glutathione (GSH) [7]. The gene discussed is NFKB1; the disease is cancer.